本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apogee Therapeutics

78.54
+1.191.54%
盤後77.58-0.9600-1.22%16:44 EST
成交量:275.67萬
成交額:2.17億
市值:53.66億
市盈率:-18.01
高:80.99
開:77.77
低:77.31
收:77.35
52周最高:80.99
52周最低:26.20
股本:6,832.02萬
流通股本:4,747.16萬
量比:2.91
換手率:5.81%
股息:- -
股息率:- -
每股收益(TTM):-4.3614
每股收益(LYR):-3.3001
淨資產收益率:-38.41%
總資產收益率:-25.26%
市淨率:9.15
市盈率(LYR):-23.80

資料載入中...

2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

重要事件披露

Form 8-K - Current report
2025/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

重要事件披露

Form 8-K - Current report
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/24

重要事件披露

Form 8-K - Current report
2024/10/04

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors